Cargando…

PAX2 induces vascular-like structures in normal ovarian cells and ovarian cancer

In adult tissue, the paired box 2 (PAX2) protein is expressed in healthy oviductal, but not normal ovarian surface epithelial cells. PAX2 is expressed in a subset of cases of serous ovarian carcinoma; however, the role of PAX2 in the initiation and progression of ovarian cancer remains unknown. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alwosaibai, Kholoud, Al-Hujaily, Ensaf M., Alamri, Salmah, Ghandorah, Salim, Garson, Kenneth, Vanderhyden, Barbara C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117948/ https://www.ncbi.nlm.nih.gov/pubmed/35601066 http://dx.doi.org/10.3892/etm.2022.11339

Ejemplares similares

PAX2 maintains the differentiation of mouse oviductal epithelium and inhibits the transition to a stem cell-like state
por: Alwosaibai, Kholoud, et al.
Publicado: (2017)

PD-L1 is highly expressed in ovarian cancer and associated with cancer stem cells populations expressing CD44 and other stem cell markers
por: Alwosaibai, Kholoud, et al.
Publicado: (2023)

PAX2 promotes epithelial ovarian cancer progression involving fatty acid metabolic reprogramming
por: Feng, Yan, et al.
Publicado: (2020)

A New Spontaneously Transformed Syngeneic Model of High-Grade Serous Ovarian Cancer with a Tumor-Initiating Cell Population
por: McCloskey, Curtis W., et al.
Publicado: (2014)

Technical challenges and limitations of current mouse models of ovarian cancer
por: Garson, Kenneth, et al.
Publicado: (2012)

GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer
por: Hodgkinson, Kendra, et al.
Publicado: (2018)

PAX2 Expression in Ovarian Cancer
por: Song, Huijuan, et al.
Publicado: (2013)

The significance of ovarian fibrosis
por: Landry, David A., et al.
Publicado: (2020)

UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer
por: Hardy, Laura R., et al.
Publicado: (2018)

The PAX8 cistrome in epithelial ovarian cancer
por: Adler, Emily K., et al.
Publicado: (2017)

Animal models of ovarian cancer
por: Vanderhyden, Barbara C, et al.
Publicado: (2003)

PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis
por: Yun, Bo Seong, et al.
Publicado: (2022)

Optimization of lentiviral vector production using polyethylenimine-mediated transfection
por: TANG, YONG, et al.
Publicado: (2015)

Recruiting Immunity for the Fight against Colorectal Cancer: Current Status and Challenges
por: Al-Hujaily, Ensaf M., et al.
Publicado: (2022)

PAX8 and MECOM are interaction partners driving ovarian cancer
por: Bleu, Melusine, et al.
Publicado: (2021)

Development of Novel Immunotherapies for Multiple Myeloma
por: Al-Hujaily, Ensaf M., et al.
Publicado: (2016)

PAX2 Expression in Low Malignant Potential Ovarian Tumors and Low-Grade Ovarian Serous Carcinomas
por: Tung, Celestine S., et al.
Publicado: (2009)

Targeting TBP-Associated Factors in Ovarian Cancer
por: Ribeiro, Jennifer R., et al.
Publicado: (2014)

A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells
por: Di Palma, Tina, et al.
Publicado: (2014)

Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
por: McCloskey, Curtis W., et al.
Publicado: (2018)

PAX8 is a potential marker for the diagnosis of primary epithelial ovarian cancer
por: Chai, Hong-Juan, et al.
Publicado: (2017)

Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancer
por: Corona, Rosario I., et al.
Publicado: (2020)

17β-Estradiol sensitizes ovarian surface epithelium to transformation by suppressing Disabled-2 expression
por: Vuong, Nhung H., et al.
Publicado: (2017)

The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy
por: Rodriguez, Galaxia M., et al.
Publicado: (2018)

Vascular normalization: reshaping the tumor microenvironment and augmenting antitumor immunity for ovarian cancer
por: Yu, Ping, et al.
Publicado: (2023)

The Tumor Immune Profile of Murine Ovarian Cancer Models: An Essential Tool for Ovarian Cancer Immunotherapy Research
por: Rodriguez, Galaxia M., et al.
Publicado: (2022)

Fetal programming: in utero exposure to acrylamide leads to intergenerational disrupted ovarian function and accelerated ovarian aging
por: Aldawood, Nouf, et al.
Publicado: (2022)

Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma
por: de Cristofaro, Tiziana, et al.
Publicado: (2016)

Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci
por: Kar, Siddhartha P, et al.
Publicado: (2017)

PAX8 as a Potential Target for Ovarian Cancer: What We Know so Far
por: Di Palma, Tina, et al.
Publicado: (2022)

17β-estradiol upregulates GREB1 and accelerates ovarian tumor progression in vivo
por: Laviolette, Laura A, et al.
Publicado: (2014)

Non-canonical WNT5a regulates Epithelial-to-Mesenchymal Transition in the mouse ovarian surface epithelium
por: Abedini, Atefeh, et al.
Publicado: (2020)

The utility of PAX8 and SATB2 immunohistochemical stains in distinguishing ovarian mucinous neoplasms from colonic and appendiceal mucinous neoplasm
por: Aldaoud, Najla, et al.
Publicado: (2019)

Transcriptional heterogeneity of stemness phenotypes in the ovarian epithelium
por: Carter, Lauren E., et al.
Publicado: (2021)

PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors
por: Shi, Kaixuan, et al.
Publicado: (2019)

PAX8 lineage-driven T cell engaging antibody for the treatment of high-grade serous ovarian cancer
por: Lee, Emily, et al.
Publicado: (2021)

PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome
por: Salvi, Amrita, et al.
Publicado: (2022)

Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium
por: Rodgers, Laura H., et al.
Publicado: (2016)

Presence of activin signal transduction in normal ovarian cells and epithelial ovarian carcinoma
por: Ito, I, et al.
Publicado: (2000)

A genome-wide strategy to identify causes and consequences of retrotransposon expression finds activation by BRCA1 in ovarian cancer
por: Alkailani, Maisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2h05iq8buid3321kgrq8141n3o